These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20812318)

  • 1. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.
    Golden-Mason L; Cox AL; Randall JA; Cheng L; Rosen HR
    Hepatology; 2010 Nov; 52(5):1581-9. PubMed ID: 20812318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced natural killer cell activity is found in exposed uninfected recipients of hepatitis C-contaminated blood.
    Ow MM; Hegazy D; Warshow UM; Cramp ME
    J Viral Hepat; 2018 Mar; 25(3):245-253. PubMed ID: 29063663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users.
    Sugden PB; Cameron B; Mina M; Lloyd AR;
    J Hepatol; 2014 Oct; 61(4):738-45. PubMed ID: 24845613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
    Yang CM; Yoon JC; Park JH; Lee JM
    PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.
    Verstrepen BE; Nieuwenhuis IG; Mooij P; Bogers WM; Boonstra A; Koopman G
    Clin Exp Immunol; 2016 Jul; 185(1):42-9. PubMed ID: 26850369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
    Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
    J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.
    Mina MM; Cameron B; Luciani F; Vollmer-Conna U; Lloyd AR;
    J Viral Hepat; 2016 Jun; 23(6):464-72. PubMed ID: 26833632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
    Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
    J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.
    Alter G; Jost S; Rihn S; Reyor LL; Nolan BE; Ghebremichael M; Bosch R; Altfeld M; Lauer GM
    J Hepatol; 2011 Aug; 55(2):278-88. PubMed ID: 21168454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of natural killer cells by hepatitis C virus particles in vitro.
    Farag MM; Weigand K; Encke J; Momburg F
    Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
    Nattermann J; Feldmann G; Ahlenstiel G; Langhans B; Sauerbruch T; Spengler U
    Gut; 2006 Jun; 55(6):869-77. PubMed ID: 16322112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.
    Yoon JC; Lim JB; Park JH; Lee JM
    J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity.
    Golden-Mason L; Stone AE; Bambha KM; Cheng L; Rosen HR
    Hepatology; 2012 Oct; 56(4):1214-22. PubMed ID: 22505144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD56
    Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
    J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
    Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
    BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.
    De Maria A; Fogli M; Mazza S; Basso M; Picciotto A; Costa P; Congia S; Mingari MC; Moretta L
    Eur J Immunol; 2007 Feb; 37(2):445-55. PubMed ID: 17273991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.
    Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
    Stegmann KA; Björkström NK; Ciesek S; Lunemann S; Jaroszewicz J; Wiegand J; Malinski P; Dustin LB; Rice CM; Manns MP; Pietschmann T; Cornberg M; Ljunggren HG; Wedemeyer H
    J Infect Dis; 2012 May; 205(9):1351-62. PubMed ID: 22457290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
    Bozzano F; Picciotto A; Costa P; Marras F; Fazio V; Hirsch I; Olive D; Moretta L; De Maria A
    Eur J Immunol; 2011 Oct; 41(10):2905-14. PubMed ID: 21695691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.